About   Help   FAQ
Mammalian Phenotype Ontology Annotations
Query Results - Summary
Symbol
Name
ID
Ins2
insulin II
MGI:96573
96 phenotypes from 8 alleles in 12 genetic backgrounds
Export: Excel File
Allelic Composition
Genetic Background
Annotated Term Reference
Ins2Akita/Ins2+
C57BL/6-Ins2Akita
abnormal Leydig cell morphology J:108948
abnormal mitochondrion morphology J:108948
abnormal pancreatic beta cell morphology J:47883
akinesia J:125256
decreased body weight J:125256
decreased bone mineral density J:108948
decreased circulating insulin level J:40063
decreased insulin secretion J:40063, J:47883
decreased subcutaneous adipose tissue amount J:108948
degranulated pancreatic beta cells J:47883
hydronephrosis J:40063
hyperglycemia J:40063, J:125256
hypoactivity J:125256
impaired glucose tolerance J:40063
increased anxiety-related response J:125256
increased fluid intake J:125256
kyphosis J:108948
polydipsia J:40063
polyphagia J:125256
polyuria J:40063
postnatal growth retardation J:40063
premature death J:40063, J:108948
Ins2Akita/Ins2+
C57BL/6-Ins2Akita/J
abnormal astrocyte morphology J:99412
abnormal microglial cell morphology J:99412
abnormal response to transplant J:76224
abnormal retinal ganglion layer morphology J:99412
abnormal retinal neuronal layer morphology J:99412
abnormal retinal vasculature morphology J:99412
decreased body weight J:99412
hyperglycemia J:76224, J:99412
increased insulin sensitivity J:76224
increased leukocyte cell number J:99412
increased retinal apoptosis J:99412
increased vascular permeability J:99412
Ins2Akita/Ins2+
C.B6N-Ins2Akita
albuminuria J:198186
expanded mesangial matrix J:198186
glomerulosclerosis J:198186
increased renal glomerular filtration rate J:198186
Ins2Akita/Ins2+
involves: C3H * C57BL/6NJcl * C57BL/6NSlc
hyperglycemia J:40063
impaired glucose tolerance J:40063
Ins2Akita/?
involves: C57BL/6NSlc
abnormal cardiac muscle contractility J:130021
abnormal glucose homeostasis J:130021
abnormal heart left ventricle morphology J:130021
abnormal heart morphology J:130021
decreased adipocyte glucose uptake J:130021
decreased body fat mass J:130021
decreased body weight J:130021
decreased circulating insulin level J:130021
decreased circulating triglyceride level J:130021
decreased liver triglyceride level J:130021
decreased muscle cell glucose uptake J:130021
decreased respiratory quotient J:130021
decreased triglyceride level J:130021
heart left ventricle hypertrophy J:130021
hyperglycemia J:130021
hypoactivity J:130021
increased adipocyte glucose uptake J:130021
increased carbon dioxide production J:130021
increased energy expenditure J:130021
increased food intake J:130021
increased oxygen consumption J:130021
insulin resistance J:130021
thick interventricular septum J:130021
Ins2Akita/Ins2+
involves: C57BL/6NSlc
abnormal pancreatic islet morphology J:200802
decreased body weight J:200802
decreased circulating leptin level J:200802
decreased insulin secretion J:200802
normal homeostasis/metabolism phenotype J:200802
increased circulating glucose level J:200802
increased food intake J:200802
Ins2Akita/Ins2Akita
C57BL/6-Ins2Akita
abnormal pancreatic alpha cell morphology J:47883
abnormal pancreatic beta cell morphology J:47883
decreased insulin secretion J:47883
hyperglycemia J:47883
postnatal lethality J:47883
small pancreatic islets J:47883
Ins2Akita/Ins2Akita
C57BL/6-Ins2Akita/J
hyperglycemia J:76224
premature death J:76224
Ins2Akita/Ins2Akita
C.B6N-Ins2Akita
abnormal glomerular capillary morphology J:198186
abnormal kidney interstitium morphology J:198186
albuminuria J:198186
decreased body weight J:198186
expanded mesangial matrix J:198186
glomerulosclerosis J:198186
hyperglycemia J:198186
increased renal glomerular filtration rate J:198186
increased renal glomerulus basement membrane thickness J:198186
premature death J:198186
renal glomerular protein deposits J:198186
Ins2Akita/Ins2Akita
involves: C57BL/6NSlc
abnormal pancreas physiology J:156725
decreased circulating insulin level J:156725
decreased insulin secretion J:156725
decreased pancreatic beta cell mass J:156725
hematoma J:168556
hyperglycemia J:156725
increased pancreatic islet cell apoptosis J:156725
Ins2C95S/Ins2+
C3HeB/FeJ-Ins2C95S
abnormal pancreatic beta cell morphology J:122098
abnormal pancreatic beta cell physiology J:122098
abnormal pancreatic islet morphology J:122098
decreased body weight J:122098
decreased circulating insulin level J:122098
decreased insulin secretion J:122098
decreased pancreatic beta cell number J:122098
disorganized pancreatic islets J:122098
hyperglycemia J:122098, J:137483
increased circulating glucose level J:122098
increased pancreatic alpha cell number J:122098
increased susceptibility to autoimmune diabetes J:122098
increased urine glucose level J:122098
insulin resistance J:122098
Ins2C95S/Ins2C95S
C3HeB/FeJ-Ins2C95S
decreased body weight J:122098
increased circulating glucose level J:122098
increased susceptibility to autoimmune diabetes J:122098
increased urine glucose level J:122098
premature death J:122098
Ins2tm1(cre/ERT2)Kcmm/Ins2tm1(cre/ERT2)Kcmm
Not Specified
normal homeostasis/metabolism phenotype J:171567
Ins2tm1Delt/Ins2+
involves: 129S2/SvPas * Black Swiss
absent pancreatic beta cells J:94589
decreased pancreatic alpha cell number J:94589
dehydration J:94589
hepatic steatosis J:94589
increased circulating ketone body level J:94589
increased urine glucose level J:94589
postnatal growth retardation J:94589
postnatal lethality, complete penetrance J:94589
small pancreatic islets J:94589
Ins2tm1Delt/Ins2tm1Jja
involves: 129S2/SvPas
decreased pancreatic beta cell number J:94589
Ins2tm1Jja/Ins2tm1Jja
involves: 129S2/SvPas
increased insulin secretion J:77595
increased pancreatic beta cell mass J:77595
increased pancreatic beta cell number J:77595
Ins2tm1Jja/Ins2tm1Jja
NOD.129S2-Ins2tm1Jja
abnormal glucose homeostasis J:85309
increased anti-insulin autoantibody level J:85309
insulitis J:85309
Ins2tm1Nagy/Ins2tm1Nagy
involves: 129S1/Sv * 129X1/SvJ * Hsd:ICR
no abnormal phenotype detected J:153719
Ins2tm1Rll/Ins2tm1Rll
Not Specified
normal homeostasis/metabolism phenotype J:196410
Tg(H2-Ea-Ins2)1Wehi/0
NOD/ShiLtJWehi-Tg(H2-Ea-Ins2)1Wehi
abnormal T cell proliferation J:100232
normal endocrine/exocrine gland phenotype J:100232
normal immune system phenotype J:100232
salivary gland inflammation J:100232
Tg(H2-Ea-Ins2)1Wehi/Tg(H2-Ea-Ins2)1Wehi
NOD/ShiLtJWehi-Tg(H2-Ea-Ins2)1Wehi
abnormal CD8-positive, alpha beta T cell morphology J:117352
decreased anti-insulin autoantibody level J:117352
decreased T cell proliferation J:117352
normal hematopoietic system phenotype J:117352
normal immune system phenotype J:117352

Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Tumor Biology (MTB), Gene Ontology (GO), MouseCyc
Citing These Resources
Funding Information
Warranty Disclaimer & Copyright Notice
Send questions and comments to User Support.
last database update
05/15/2018
MGI 6.12
The Jackson Laboratory